Stock Split History
ETFs Holding ABMD »    ABMD Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ABIOMED is a provider of temporary mechanical circulatory support devices, and it provides a continuum of care to heart failure patients. Co.'s products include: Impella 2.5®, which is a percutaneous micro heart pump with an integrated motor and sensors; which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, which is a percutaneous catheter-based axial flow pump that is designed to allow more than four liters of flow per minute. According to our ABIOMED stock split history records, ABIOMED has had 1 split.
ABIOMED stock split history picture
ABIOMED (ABMD) has 1 split in our ABIOMED stock split history database. The split for ABMD took place on October 02, 2000. This was a 2 for 1 split, meaning for each share of ABMD owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.

When a company such as ABIOMED splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the ABIOMED stock split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ABIOMED shares, starting with a $10,000 purchase of ABMD, presented on a split-history-adjusted basis factoring in the complete ABIOMED stock split history. ABIOMED split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/20/2009
End date: 07/17/2019
Start price/share: $7.92
End price/share: $260.06
Dividends collected/share: $0.00
Total return: 3,183.59%
Average Annual Total Return: 41.80%
Starting investment: $10,000.00
Ending investment: $328,357.36
Years: 10.00
Date Ratio
10/02/20002 for 1
ABMD is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ABT Split History
ABV Split History
ACER Split History
ACET Split History
ACHC Split History
ACHV Split History
ACST Split History
ACUR Split History
ADK Split History
ADMP Split History

Also explore: ABMD shares outstanding history

Neuralstem, Inc. (CUR)
Francesca's Holdings Corporation (FRAN)
China Green Agriculture, Inc. (CGA)
Xenetic Biosciences, Inc. (XBIO)
Yuma Energy, Inc. (YUMA)
Avinger, Inc. (AVGR)
Sonoma Pharmaceuticals, Inc. (SOMA)
Hudson Global, Inc. (HSON)
Jaguar Health, Inc. (JAGX)
Cesca Therapeutics Inc. (KOOL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding ABIOMED
ABIOMED Insider Buying

ABIOMED Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.